Concerning DOT1L protein expression, we identified a trend (P = 0.1) for an association with no detectable DOT1L protein expression and a better EFS in the cohort of 31 DLBCL patients tested (Figure 5C). The gene discussed is DOT1L; the disease is diffuse large B-cell lymphoma.